ARCHIVES

In Brief: Deisseroth Leaves M.D. Anderson To Head Yale’s Oncology, Gene Therapy Programs

This article is from The Cancer Letter archive.

Vol. 21 No. 35 | September 15, 1995

Download PDF Visit The Full Archive

Related Articles

NCAB Committee To Propose Event Marking Cancer Act

August 2, 1991

New Firm Steps Onto Texas Battleground for Control Over Office-Based Oncology

November 22, 1996

Turmoil in Texas: DePinho Recommended AVEO Stock on CNBC Six Days After FDA Said New Trial Was Needed

May 10, 2013

Rogers-Kennedy Impasses Still Blocks Training Grant Bill

April 19, 1974

Gene Therapy Shows Positive Results In Phase III Trial

July 25, 2008

MAP Says It Will Continue Operating With Private Funds

April 18, 1986